Healthcare
MVM Partners leads $62m round for SkyCell
Investors including the Swiss Entrepreneurs Fund also back the pharmaceutical containers producer
Partech closes third seed fund of $100m
Partech Entrepreneur III surpasses its original target of $80m
MVM invests $14m in MDxHealth
MVM is drawing equity from MVM Fund V, which held a first close on £150m in November 2018
VCs in $80m series-B for Compass Pathways
Compass intends to use the funds to expand upon its lead programme in psilocybin therapy
Q&A: SHS's Alilovic on healthtech investing
New managing partner Sascha Alilovic talks to Unquote about the healthtech investor's plans
Sofinnova invests €16m in Italian biotech company Genespire
GP deploys capital from Sofinnova Telethon Fund, which targets early-stage Italian biotech companies
Consortium backs series-B for Leon-Nanodrugs
Investors in the biotechnology company comprise VCs and corporates, including new investor BayBG
Blue Venture and HealthQuest invest in UK company Perspectum
Company has reportedly raised $47m since being founded
Wellington Partners makes seed investment in Sirs Therapeutics
Life science and technology investor Wellington is the majority owner of the early-stage company
V4C, Ananda Impact acquire Doktor 24
Investment will finance Doktor 24's acquisition of two other healthcare businesses in Hungary
Main Capital buys majority stake in health software firm Alfa
Netherlands-based GP paid тЌ15-20m for its stake in the company
Redmile buys additional 12.67% of Redx
Upon completion of the transaction, Redmile will own a total of 110.6 million Redx shares
Cowen Healthcare in €47m extension round for AM-Pharma
Round comprises €23m in equity and a €24m finance facility provided by the European Investment Bank
York Capital, Elements Capital buy Pillarstone-backed Famar
In addition to Famar Italia, the Italian subsidiary of Famar, the deal also includes Famar Properties
Arx reaps 3.6x on DCB trade sale
Divestment generates an overall cash-on-cash return of 3.6x and an IRR of more than 25%
Immatics acquired by sponsor-backed Arya
Immatics will receive proceeds of approximately $252m upon closing of the deal
CBPE sells SpaMedica to Nordic Capital-backed Ober Scharrer
Nordic Capital is currently investing from its ninth fund, Nordic Capital IX, which closed on тЌ4.3bn
Turenne backs Banook MBO
GP invests from its Capital Sante 2 fund, which held a first close on €100m in March 2019
LSP closes sixth fund on $600m
Fund invests in European companies developing new medications and medical technologies
Summit-backed Viroclinics acquires DDL
Bob van Gemen, CEO of Viroclinics Biosciences, will serve as CEO of the combined organisation
Limerstone buys Patricia Whites and Country Cousins for £14m
Grant Thornton was engaged to explore an auction process for the assets in December 2019
LDC acquires stake in healthcare company Ashtons
Founder Laurence Sprey will exit the company, with LDC backing the management team
Five Arrows to sell stake in Dutscher to LBO France
Five Arrows previously acquired a minority stake in Dutscher in 2013
GA leads $130m series-B for Immunocore
Five existing investors, including Eli Lilly and RTW Investments, take part in the round